Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxium 500 in chronic venous insufficiency (CVI) class C3–C4
2009-013391-44Phase 4Completed
- Sponsor
- OM Pharma
- Start
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in venous stasis comparing Doxium 500 with Placebo (2 arms). Primary endpoint: Relative volume change in the most pathological leg. Started Dec 2009; status: completed.
02
Drugs
calcium dobesilate
03
Conditions
venous stasis
Beyond the preview
Go deeper on 2009-013391-44.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013391-44.